Gaurav Bajaj

Gaurav Bajaj is an experienced clinical pharmacologist with a robust background in oncology and pharmacometrics. Currently serving as Senior Director of Clinical Pharmacology & Quantitative Sciences at Genmab since May 2019, Gaurav previously held various leadership roles at Bristol-Myers Squibb, including Associate Director and Director positions, where significant contributions were made to phase-III programs and regulatory submissions for nivolumab. Gaurav's career spans several prestigious institutions, including The Children's Hospital of Philadelphia and Purdue University, with a focus on drug development and clinical pharmacology strategies. Gaurav holds a Ph.D. in Pharmacology from Oregon State University and advanced degrees in Pharmacy from Delhi University, complemented by early training in community pharmacy and pharmaceutical chemistry.